BioPartners - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsBioPartners

BioPartners

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Ribavirin biopartners	Ribavirin	2010-04-06		Chronic hepatitis c , Virus diseases , Respiratory syncytial virus infections , West nile fever , Human adenovirus infections , Renal cell carcinoma , Colorectal neoplasms , Brain neoplasms , Hepatocellular carcinoma , Essential thrombocythemia , Multiple myeloma , Sezary syndrome , Skin neoplasms , Melanoma , Chronic hepatitis b , Hemangioma , Thrombocytopenia , Macular degeneration , Mycosis fungoides , Hairy cell leukemia , Hepatitis d , Hypereosinophilic syndrome , Kaposi sarcoma , Warts , Skin ulcer , Cryoglobulinemia , Ileal neoplasms
Somatropin biopartners	Somatropin	2013-08-05		Heart failure , Prader-willi syndrome , Cachexia , Pituitary dwarfism , Turner syndrome , Noonan syndrome , Dwarfism , Growth
Valtropin	Somatropin	2006-04-24		Heart failure , Prader-willi syndrome , Cachexia , Pituitary dwarfism , Turner syndrome , Noonan syndrome , Dwarfism , Growth

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

pituitary dwarfism

,

pituitary diseases

,

endocrine system diseases

Interferon beta

,

ulcerative colitis

,

merkel cell carcinoma

,

polyomavirus infections

,

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

invasive candidiasis

,

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia

,

relapsing-remitting multiple sclerosis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use